Navigation Links
NxStage(R) Announces Extension of Medisystems Needle Supply and Distribution Agreement

LAWRENCE, Mass., July 21 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that its Medisystems subsidiary has extended for three years a supply and distribution agreement with Fenwal, Inc. of Lake Zurich, Ill. Medisystems provides needle sets and assemblies to Fenwal, a global medical technology company focused on improving blood collection, separation, safety and availability for patient care. Medisystems products involved in this agreement include the MasterGuard needle sets with FingerShield(TM) safety technology, the leading worldwide needle-stick prevention device.

"Medisystems is delighted to continue its relationship with Fenwal," said Jeffrey H. Burbank, Chief Executive Officer of NxStage Medical. "This agreement provides further validation of our ability to continue to drive steady growth in end-user demand with Medisystems' innovative, high quality, value added product offerings."

MasterGuard Anti-Stick Needle Protector is the only guarded pheresis needle proven to reduce needlestick injuries, as compared to conventional, unguarded needles. Medisystems' patented FingerShield technology helps protect medical technicians' and caregivers' pressure-holding fingers during pheresis procedures. MasterGuard is also designed to allow for optimal visualization of the needle and does not interfere with site selection, cannulation technique or tapedown for patient safety and procedural efficacy during pheresis.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of End Stage Renal Disease (ESRD) and acute kidney failure. Medisystems, a wholly owned subsidiary of NxStage, designs, manufactures, imports and distributes innovative medical devices, primarily for use in dialysis and related blood treatments ( For more information on NxStage and its products, please visit the company's website at

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including factors that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended March 31, 2009. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE NxStage Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NxStage(R) Announces Medisystems(R) Bloodline Distribution Agreement with Gambro
2. NxStage(R) Ranked 14th Fastest Growing Company in North America on Deloittes 2008 Technology Fast 500
3. NxStage(R) Achieves Milestone with 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy
4. Emil Paganini, MD, Joins NxStage(R) as Critical Care Medical Advisor
5. NxStage(R) Medical to Report Fourth Quarter & Full Year 2007 Financial Results on Tuesday, February 12th
6. The Neutraceutical Company Announces Powerful New Feel-Good Product
7. Domain Registration Corp. Announces Name Change to BioPharm Asia, Inc.
8. PTS, Inc. Subsidiary Disability Access Corporation Announces $535,000 in New Contracts and Inspection Orders for July 2009
9. Owensboro Medical Health System Announces Results of Its Modified Dutch Auction Tender Offer
10. PTS, Inc. Subsidiary Disability Access Corporation Announces $535,000 in New Contracts and Inspection Orders for July 2009
11. Domain Registration Corp. Announces Name Change to BioPharm Asia, Inc.
Post Your Comments:
(Date:6/26/2016)... ... , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment center ... Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This annual ... the world’s leading providers of cereal and other breakfast foods. Its residents often refer ...
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)... , June 26, 2016 ... care operating models within the health care industry is ... financial efficiency , Deloitte offers a suite of ... business issues impacting efficient cost optimization: labor resource analysis, ... These services facilitate better outcomes and better economics ...
(Date:6/24/2016)...  Collagen Matrix, Inc., ("Collagen Matrix") the driving ... collagen and mineral based medical devices for tissue ... Messer has joined the company as Vice ... growing portfolio of oral surgery, neurosurgery, orthopaedic and ... the Collagen Matrix executive team as an accomplished ...
Breaking Medicine Technology: